CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Mateon Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period

OXGN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



OXGN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
Y / Y Current Liabilities Growth -12.11 % 9.81 % 7.74 % -26.45 % -18.68 %
Y / Y Cash & cash equivalent Growth -44.55 % -60.71 % -97.21 % -90.74 % -90.13 %
Quick Ratio for Trailing Twelve Months Period 0.88 1.02 1.65 3.34 5.14
Total Ranking # # # # #
Seq. Current Liabilities Growth -31.12 % -0.07 % 25.79 % 1.51 % -13.95 %
Seq. Cash & cash equivalent Growth -46.19 % 743.78 % -79.1 % -41.56 % -61.87 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite year on year decrease in Mateon Therapeutics Inc's average Current Liabilities to $1 millions, Quick Ratio for Trailing Twelve Months Period to 0.88 above company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest Quick Ratio for Trailing Twelve Months Period. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about OXGN
Quick Ratio OXGN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2018, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Hedgepath Pharmaceuticals, Inc.  2.40 
Armata Pharmaceuticals, Inc.  2.31 
Oncocyte Corp  2.28 
Citius Pharmaceuticals, Inc.  2.15 
Soligenix, Inc.  2.13 
Nanostring Technologies Inc  2.09 
Cytrx Corp  2.00 
Osiris Therapeutics, Inc.  1.98 
Replicel Life Sciences Inc.  1.97 
Protalix Biotherapeutics, Inc.  1.96 
Diffusion Pharmaceuticals Inc.  1.92 
Qiagen Nv  1.86 
Aytu Bioscience, Inc  1.77 
Repligen Corp  1.77 
Biocryst Pharmaceuticals Inc  1.74 
Midatech Pharma Plc  1.74 
Uluru Inc.  1.72 
Bio-techne Corp  1.69 
Azurrx Biopharma, Inc.  1.67 
Intelgenx Technologies Corp.  1.66 
Quotient Ltd  1.61 
Xenetic Biosciences, Inc.  1.60 
Cv Sciences, Inc.  1.57 
Dimension Therapeutics, Inc.  1.57 
Q Biomed Inc.  1.56 
Amarillo Biosciences Inc  1.54 
Kazia Therapeutics Ltd  1.53 
Biopharmx Corporation  1.46 
Clementia Pharmaceuticals Inc.  1.45 
Apollo Endosurgery, Inc.  1.44 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DGLY's Profile

Stock Price

DGLY's Financials

Business Description

Fundamentals

Charts & Quotes

DGLY's News

Suppliers

DGLY's Competitors

Customers & Markets

Economic Indicators

DGLY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071